News
Quatrefolic®, MenaQ7® & vitaMK7® protagonist at Korean Congress of Samoh Pharm in Seoul
5 July 2022
On 14th July, more than 100 people will attend the "Active Folate and Vitamin K2 Seminar" organized by Gnosis by Lesaffre and key partner Samoh Pharm to share science and opportunities on Quatrefolic®, MenaQ7® and vitaMK7®.
The “Active Folate and Vitamin K2 Seminar” will be held in Seoul at Coex Convention & Exhibition Center and will welcome professionals from over 40 companies gathered at same location for the first time since COVID-19, to discuss on Quatrefolic® and Vitamin K2, namely MenaQ7® and vitaMK7®. There is a keen interest from the market on this innovative folate, and Vitamin K2 which is anticipated to be monographed later this year.
The 4th generation innovative folate and most effective vitamin K2 are here. Want to know more?
In the first part of the seminar, Silvia Pisoni, Global Market Manager of Gnosis by Lesaffre, will share on Quatrefolic® mechanism of action – with specific focus on the differences among the other folate forms, health applications and market trends. She will provide an extensive description of the exclusive benefits of this active folate patented and produced exclusively by Gnosis by Lesaffre.
The second half of the meeting will focus on Vitamin K2, menaquinone-7 (MK-7). Silvia Pisoni will talk about this vital nutrient newly recognized for supporting bone and cardiovascular health, vitamin K2 mechanism, MenaQ7® clinical validation and Gnosis by Lesaffre’s vitamin K2 solutions platforms.
Why these two vitamins, folate (vitamin B9) and vitamin K2 in the limelight?
Today, even more so, nutritional industry consumers are looking for bioactive and effective ingredients and are interested in understanding the differences between the different forms available, like for folate and vitamin K2, and why these are more beneficial to human health.
Quatrefolic®, the glucosamine salt of 5-MethylTetraHydroFolate (5-MTHF), the bioactive form of folate that doesn’t need to be metabolized by a specific enzyme, methylenetetrahydrofolate reductase (MTHFR), often polymorphic, before to be used by our body.
Globally renowned for being the vitamin K2 market standard for clinical validation, MenaQ7® is patent protected for several health benefits, from bone to cardiovascular health and beyond. The subject of more than 20 clinical studies, MenaQ7® is the premium option for brands and medical professionals that require ingredients with proven efficacy and safety. vitaMK7® ingredient uses a microorganism strain to power its proprietary fermentation process – the same species responsible for creating natto in Japan, the globally recognized source of K2 in the diet.
If you are unable to join us physically at this event, subscribe to our newsletter or visit our partner’s website to be sure not to miss our news and benefits on Quatrefolic®!
